BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 15842648)

  • 81. Characterization of Leiomyomatoid Angiomatous Neuroendocrine Tumour (LANT)-like Tumour in the Myometrium with Histopathological Examination.
    Hayashi T; Ichimura T; Kasai M; Sano K; Zharhary D; Shiozawa T; Yaegashi N; Konishi I
    Anticancer Res; 2017 Apr; 37(4):1765-1772. PubMed ID: 28373439
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Activin A in Inflammation, Tissue Repair, and Fibrosis: Possible Role as Inflammatory and Fibrotic Mediator of Uterine Fibroid Development and Growth.
    Protic O; Islam MS; Greco S; Giannubilo SR; Lamanna P; Petraglia F; Ciavattini A; Castellucci M; Hinz B; Ciarmela P
    Semin Reprod Med; 2017 Nov; 35(6):499-509. PubMed ID: 29100238
    [No Abstract]   [Full Text] [Related]  

  • 83. Percutaneous ultrasound guided uterine needle biopsy.
    Wood C; Hurley VA; Fortune DW; Leoni M
    Med J Aust; 1993 Apr; 158(7):458-60. PubMed ID: 8469194
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Heterotopic striated muscle in the myometrium in a patient with myoma uteri.
    Terada S; Tomita Y; Nakagawa T; Akasofu K; Mizukami Y
    Gynecol Obstet Invest; 1991; 32(3):191-2. PubMed ID: 1757003
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Differential Immunoreactivity of p16 in leiomyosarcomas and leiomyoma variants.
    Gannon BR; Manduch M; Childs TJ
    Int J Gynecol Pathol; 2008 Jan; 27(1):68-73. PubMed ID: 18156978
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Identification of uterine telocytes and their architecture in leiomyoma.
    Aleksandrovych V; Białas M; Pasternak A; Bereza T; Sajewicz M; Walocha J; Gil K
    Folia Med Cracov; 2018; 58(3):89-102. PubMed ID: 30521514
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Reduced expression of 14-3-3 gamma in uterine leiomyoma as identified by proteomics.
    Lv J; Zhu X; Dong K; Lin Y; Hu Y; Zhu C
    Fertil Steril; 2008 Nov; 90(5):1892-8. PubMed ID: 18054924
    [TBL] [Abstract][Full Text] [Related]  

  • 88. The effects of the selective progesterone receptor modulator asoprisnil on the morphology of uterine tissues after 3 months treatment in patients with symptomatic uterine leiomyomata.
    Williams AR; Critchley HO; Osei J; Ingamells S; Cameron IT; Han C; Chwalisz K
    Hum Reprod; 2007 Jun; 22(6):1696-704. PubMed ID: 17339234
    [TBL] [Abstract][Full Text] [Related]  

  • 89. [Relationship of the changes in the capillary network and neural elements of the myometrium to the sizes of the tumorous nodes in uterine fibromyoma].
    Savitskiĭ GA; Pavlovich VG
    Akush Ginekol (Mosk); 1976 Jul; (7):13-5. PubMed ID: 1020783
    [No Abstract]   [Full Text] [Related]  

  • 90. Evaluation of KI-67 expression in uterine leiomyoma and in healthy myometrium: a pilot study.
    Eulálio Filho WMN; Soares EAS; Lima MSO; Brazil EDDN; Rodrigues RMM; Zeron RMC; Silva BB; Costa PVL
    Rev Assoc Med Bras (1992); 2019 Dec; 65(12):1459-1463. PubMed ID: 31994626
    [TBL] [Abstract][Full Text] [Related]  

  • 91. The normal human myometrium has a vascular spatial gradient absent in small fibroids.
    Aitken E; Khaund A; Hamid SA; Millan D; Campbell S
    Hum Reprod; 2006 Oct; 21(10):2669-78. PubMed ID: 16807279
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Fatty tumours of the uterus.
    Pounder DJ
    J Clin Pathol; 1982 Dec; 35(12):1380-3. PubMed ID: 7174848
    [TBL] [Abstract][Full Text] [Related]  

  • 93. A novel selective progesterone receptor modulator asoprisnil (J867) down-regulates the expression of EGF, IGF-I, TGFbeta3 and their receptors in cultured uterine leiomyoma cells.
    Wang J; Ohara N; Wang Z; Chen W; Morikawa A; Sasaki H; DeManno DA; Chwalisz K; Maruo T
    Hum Reprod; 2006 Jul; 21(7):1869-77. PubMed ID: 16613890
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Spindle cell lipoma.
    Comunoglu N; Comunoglu C; Ekici AI; Ozkan F; Dervişoglu S
    Pol J Pathol; 2007; 58(1):7-11. PubMed ID: 17585537
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Uterine leiomyohibernoma.
    Chen KT
    Int J Gynecol Pathol; 1999 Jan; 18(1):96-7. PubMed ID: 9891251
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Estrogen receptor alpha and beta in uterine fibroids: a basis for altered estrogen responsiveness.
    Bakas P; Liapis A; Vlahopoulos S; Giner M; Logotheti S; Creatsas G; Meligova AK; Alexis MN; Zoumpourlis V
    Fertil Steril; 2008 Nov; 90(5):1878-85. PubMed ID: 18166184
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Expression of thrombospondin 1 (TSP 1) in patients with uterine smooth muscle tumors: an immunohistochemical study.
    Bodner-Adler B; Nather A; Bodner K; Czerwenka K; Kimberger O; Leodolter S; Mayerhofer K
    Gynecol Oncol; 2006 Oct; 103(1):186-9. PubMed ID: 16595146
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Uterine fibrolipoleiomyoma: report of a case with discussion of histogenesis.
    Honoré LH
    Am J Obstet Gynecol; 1978 Nov; 132(6):635-6. PubMed ID: 717468
    [No Abstract]   [Full Text] [Related]  

  • 99. Angiomatous spindle cell lipoma: Report of three cases with immunohistochemical and ultrastructural study and reappraisal of former 'pseudoangiomatous' variant.
    Zamecnik M; Michal M
    Pathol Int; 2007 Jan; 57(1):26-31. PubMed ID: 17199739
    [TBL] [Abstract][Full Text] [Related]  

  • 100. [A case report of uterine lipoleiomyoma].
    Nasu K; Yoshiyama K; Kawano Y; Miyakawa I; Komeda Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1993 May; 45(5):475-8. PubMed ID: 8496638
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.